Related references
Note: Only part of the references are listed.Soluble VCAM-1 impairs human brain endothelial barrier integrity via integrin α-4-transduced outside-in signalling
Axel Haarmann et al.
ACTA NEUROPATHOLOGICA (2015)
Cell surface levels of endothelial ICAM-1 influence the transcellular or paracellular T-cell diapedesis across the blood-brain barrier
Michael Abadier et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Dimethyl fumarate attenuates cerebral edema formation by protecting the blood-brain barrier integrity
Reiner Kunze et al.
EXPERIMENTAL NEUROLOGY (2015)
Monomethylfumarate reduces in vitro migration of mononuclear cells
T. Dehmel et al.
NEUROLOGICAL SCIENCES (2014)
Dimethyl Fumarate (Tecfidera): A New Oral Agent for Multiple Sclerosis
Jineane V. Venci et al.
ANNALS OF PHARMACOTHERAPY (2013)
Effects of fumaric acid esters on blood-brain barrier tight junction proteins
Karelle Benardais et al.
NEUROSCIENCE LETTERS (2013)
Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier
Ruben van Doom et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Capture, crawl, cross: the T cell code to breach the blood-brain barriers
Britta Engelhardt et al.
TRENDS IN IMMUNOLOGY (2012)
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
Ralf A. Linker et al.
BRAIN (2011)
Downregulation of endothelial adhesion molecules by dimethylfumarate, but not monomethylfumarate, and impairment of dynamic lymphocyte-endothelial cell interactions
Katrin Wallbrecht et al.
EXPERIMENTAL DERMATOLOGY (2011)
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Volker Brinkmann et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Evaluation of Soluble Junctional Adhesion Molecule-A as a Biomarker of Human Brain Endothelial Barrier Breakdown
Axel Haarmann et al.
PLOS ONE (2010)
Treating multiple sclerosis with monoclonal antibodies
Mathias Buttmann et al.
Expert Review of Neurotherapeutics (2008)
Dimethylfumarate reduces leukocyte rolling in vivo through modulation of adhesion molecule expression
Simone A. Rubant et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Atorvastatin partially prevents an inflammatory barrier breakdown of cultured human brain endothelial cells at a pharmacologically relevant concentration
Mathias Buttmann et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Interferon-β is a potent inducer of interferon regulatory factor-1/2-dependent IP-10/CXCL10 expression in primary human endothelial cells
Mathias Buttmann et al.
JOURNAL OF VASCULAR RESEARCH (2007)
Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration
S. Schilling et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Evaluation of the immortalised mouse brain capillary endothelial cell line, b.End3, as an in vitro blood-brain barrier model for drug uptake and transport studies
Y Omidi et al.
BRAIN RESEARCH (2003)
Dimethylfumarate is a potent inducer of apoptosis in human T cells
F Treumer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Dimethylfumarate inhibits TNF-induced nuclear entry of NF-κB/p65 in human endothelial cells
R Loewe et al.
JOURNAL OF IMMUNOLOGY (2002)
Characteristic gene expression profile of primary human cerebral endothelial cells
BA Kallmann et al.
FASEB JOURNAL (2002)
Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier
M Gumbleton et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2001)
Share Paper
